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American men have a 60% higher incidence rate of CaP and twice the death rate of Caucasian men. CaP is also the second leading cause of cancer-related death in AA men. Paucity of investigators who conduct research on CaP disparities in minorities has often been cited as one of the barriers to research addressing minority health issues. UDC has established a strong partnership with the Lombardi Comprehensive Cancer Center (LCCC) at Georgetown University (GU) in Washington, DC. Historically, GU has a longstanding commitment to the recruitment and successful placement of minority trainees. The tumor Biology program -under the leadership of Deepak Kumar, PhD, Chair of Department of Biology at UDChas been very successful at recruiting and retaining these individuals in their training program. In the past three years, Dr. Kumar has also built tremendous collaborations with USU-CPDR toward the summer training of UDC students in CaP research.
Uniformed Services University of the Health Sciences (USU) has a worldwide reputation as a center of excellence for military and public health professionals in their education and research. USU programs are unique, related directly to enforce health protection, tropical diseases, disaster medicine, military and public health medical readiness, and adaptation to extreme environments. USU prepares outstanding scientists and health care practitioners for careers in service to the nation (www.usuhs.mil). USU-CPDR has been recognized by the DoD as the Integrated Translational Prostate Disease Research Center of Excellence with an outstanding track record for more than 20 years. CPDR integrates state-of-the-art basic and clinical science research programs and an infrastructure supporting long-term biospecimen banks, a multicenter CaP patient database and training programs for post-doctoral fellows, urology residents, and students (USUHS medical and graduate students and college and high school interns). USUHS-CPDR program affiliations include Walter Reed Army Medical Center (WRAMC) and the Joint Pathology Center (JPC), formerly known as Armed Forces Institute of Pathology (AFIP).
The objectives of the HBCU training award were:
• To recruit and motivate highly qualified undergraduate trainees from UDC • To provide them with a stimulating and intellectual environment that promotes state-of-the art training and education in CaP research • To motivate young researchers who may contribute to CaP research at Historically Black Colleges and Universities (HBCUs)
Each student admitted to the program was assigned to one of the faculty members affiliated with CPDR who served as research mentor. Students carried out a specific research project that was designed to yield some exciting data and findings within the 12-week period. Through regular laboratory meetings, seminars, and personal discussions, the students interacted with other fellow students, faculty members, and staff. At the end of the summer experience, students presented their research findings and submitted their progress reports. Each student was given a certificate of completion of achievement. In the three years of this grant period, we have trained 16 UDC undergraduate students (four more than proposed in the grant) and it has been an extremely positive and enriching experience for both the faculty members and the students. were made by Dr. Deepak Kumar (Partnering PI) at the UDC, encouraging application from undergraduate students, interested in pursuing an advanced education in medicine or medical research (Attachment 1-3). The completed applications considered for the selection process consisted of an essay describing the student's interest, academic transcripts, and letters of recommendation. In the three years of the grant period, sixteen students whose grade point average ranged from 3.2 to 3.8 were selected. The selection committee, consisted of the UDC and USU faculty advisors, the principal investigator (PI), and the Co-PI. Students were selected based on their academic credentials and interest in research.
2008:
Mr CPDR (www.cpdr.org) is committed to a multi-disciplinary approach to CaP research with over 350 publications and continues to make great strides in clinical and basic science research for improving the entire spectrum of care to include diagnosis, treatment, management, and follow-up for prostate cancer patients. The Center's strategy is to focus investigators on potential breakthrough research within its three major research programs (Basic Science, Clinical Science, and Patient Database) while maintaining the core support requirements for all of its programs. CPDR research focuses on discovery or validation of biologically significant molecular defects in CaP onset or progression towards developing novel strategies in molecular classification and treatment of the CaP. Recent ground-breaking basic science and translational investigations of the ERG as one of the most common oncogenic activations in CaP are among notable CPDR accomplishments. The CPDR program has also been in the lead on research focusing on CaP in African Americans, who are at highest risk of this disease. The different components of the USU-CPDR and collaborations that have enriched the CaP research training of the UDC students included: Multi-disciplinary team of cancer biologists, urologists, genitourinary pathologists, epidemiologists, biostatisticians, medical/bio-informatics and regulatory affairs specialists focuses on the following research areas:
• Discovery of frequent and potentially causal prostate cancer gene alterations • Identification of biomarkers that will distinguish between indolent and aggressive CaP • Development of new molecular strategies for improving prostate cancer diagnosis and prognosis • Delineation of hormonal mechanisms involved in prostate cancer onset or progression • Development and evaluation of novel molecular therapeutic agents for prostate cancer • Development and maintenance of molecular specimen resources for translational research • Development of new experimental models with focus on common prostate cancer gene alterations • Identification of molecular determinants of prostate cancer susceptibility in high-risk groups such as African-Americans • Epidemiologic research focusing on prognostic markers, racial disparity, obesity, outcomes of various modalities in CaP and quality of life of patients in relation to various treatments.
• Education of next generation of scientists in prostate cancer translational research 8 (LNCaP). The main objective was to examine whether p53 and ANXA7 pathways control cell proliferation and determine whether they work independently or in the same pathway.
Mr. Francisco Saenz (2008)
A cure for cancer can only start with better diagnosis and the molecular mechanisms underlying the disease and later development of new and better treatment. Hence, the objective was to define the role of NKX3.1 on the expression of TMPRSS2-ERG fusion gene. The results would represent a step further towards the understanding of molecular mechanisms of prostate tumorigenesis.
Mr. Emmanuel Woode (2008)
Three of the five ERG isoforms were identified at CPDR as full length prototypical gene product (type I) while the remaining two were identified to be truncated and without the ETS binding domain (type II). We hypothesize that the truncated forms act as dominant negative. Thus the truncated variants may suppress the function of the full length type.
Ms. Fiteh Yelekal (2008)
Comparative gene expression signatures of well/moderately differentiated and poorly differentiated prostate cancer (CaP) cells and transcriptional regulation analyses highlighted alterations of SPARC, and genes linked to it, in poorly differentiated CaP. Our objective is to study SPARC protein expression in a large cohort of patients by immunohistochemistry, whether the protein expression of SPARC can predict aggressive clinical behavior in retrospectively selected cohort of patients.
Ms. Zainab Afzal (2009)
ERG oncogene is activated in two-thirds of CaP patients. CPDR researchers defined qualitative and quantitative features of two main types of ERG transcripts in CaP. The goals of the project was to study the sub-cellular localization of the different isoforms of Type I: ERG: ERG1, ERG2, WT-ERG3, TM-ERG3, and Type II ERG: TM-ERG8 and to determine their transcriptional activity.
Ms. Emelia Daka (2009)
The function of miRNAs is largely unexplored in CaP. The objective of this study was to define how mir-21 and mir-127 regulate ERG that is expressed in the majority of CaP patients.
Ms. Heran Kalyie (2009)
To determine the mechanism by which Kaposi Sarcoma Herpes Virus (KSHV) may skew the endogenous cellular processes toward a state that results in aggressive growth of CaP cells.
Mr. Benjamin Ozokwere (2009)
CaP cells are known to metastasize to bone as the cancer progresses to hormone independence or refractory stage. The objective of this project was to determine whether ERG influences transdifferentiation of CaP cells into bone cells.
Mr. Henoke Shibeshi (2009)
The objective of this study was to examine if the tumor suppression activity of ANXA7 involves FGF8 in CaP cell lines (LNCaP, DU145, and PC3) and their normal counterpart (PrEC).
Ms. Tseday Tegegn (2009)
To study the role of ERG in regulating the expression of other genes using cell-line models. The other objective was to explore whether patients with ERG overexpression in their prostate tumor may have a lower serum prostate-specific antigen (PSA) level compared to patients with ERG-negative prostate tumors.
Ms. Preety Upadhyay (2009)
To assess a new aspect of ERG transcription-factor function by studying its regulation of probasin promoter (ARR2PB) commonly used in the generation of CaP transgenic mouse models. Two independent approaches were applied: (1) bioinformatic definition of ETS-binding sites in ARR2PB promoter sequence, and (2) assessment of ERG as repressor or activator for the probasin promoter in CaP cells.
Ms. Nicola Eva Abdul (2010)
Gene rearrangements leading to The TMPRSS2-Ets related gene (ERG) fusions in prostate cancer are of extreme importance, due to their high prevalence among prostate cancer patients. The cause of the gene fusions alone is not clearly understood yet. In this study, we planned to examine if proteins from biological factors such as SV40 virus caused rearrangements in mouse models.
Ms. Zainab Afzal (2010)
Shadowing a number of patients during various stages of prostate cancer diagnosis, treatment and recovery, as well as being mentored by many clinical staff members will provide a rich educational opportunity to understand this disease from the clinician's and the patient's perspective.
Ms. Christelle Donfack (2010)
Our objective was to understand the oncogenic functions of ERG by examining the localization, the expression size and quantity of ERG in prostate and other tumor cell lines such as Colo320, Molt4, KG-1, and VCaP by Western blot analysis and Immunofluorescence analysis.
Ms. Juliet Chijioke (2010)
The androgen receptor (AR) plays an essential role in the differentiation and growth of the prostate gland. The stability of androgen receptor depends on MDM2-p53 stress response pathway and PMEPA1-NEDD4-1 feedback loop, to maintain its overall homeostasis. However, the combined mechanism of PMEPA1 and NEDD4-1 to degrade AR is still not clear. Our objective was to study cooperativity of PMEPA1 and NEDD4 in degradation of AR signaling in prostate cancer.
Mr. Habib Kedir (2010)
Our objective was to develop a noninvasive urine based prostate cancer diagnostic assay with better sensitivity and specificity. Experiments focused on the stability and recovery prostate cancer cells spiked into urine using a variety of fixatives and recovery platforms.
Task 4.
Scheduled meetings/activities to monitor student's progress.
Student and mentors met every morning to discuss the plan for the experiments and in the evenings to summarize the experimental results and interpretations. Students also attended the following meetings:
• Weekly meetings: Students participated in department seminars presented by USU/CPDR faculty and researchers, as well as guest speakers, to understand the research activities and the progress in the field of CaP.
• Biweekly seminar presentations: Students presented their goals, objectives, and experimental plan for the training period in the first presentation and their progress in subsequent presentation.
• At the end of the summer experience, each student prepared and presented their research findings as PowerPoint presentations.
• Final seminar presentation: Students presented the complete project report and conclusions.
• Report Submission: Each student submitted the entire project as a hard copy and an electronic version to the supervisors. 
KEY RESEARCH ACCOMPLISHMENTS OF SUMMER INTERNS:
All sixteen UDC students, selected under HBCU Summer Undergraduate Training Program in CaP Research, have successfully completed their projects assigned to them. Highlights of their project outline and experimental results are described below:
Mr. Chiedozie Joseph Ayika (2008)
Lack of p53 tumor suppressor effect in LNCaP cells is associated with FOXO3a hyperphosphorylation.
• Lack of tumor suppressor effects of p53 in LNCaP prostate cancer cells was compared with ANXA7, which exhibited tumor suppressor activity. p53 significantly increased the phosphorylation of FOXO3A without any alteration in total FOXO3A protein • Phosphorylated FOXO3A protein was predominantly localized to the cytoplasm in • LNCaP cells infected with Adenovirus p53 vector.
• In contrast, ANXA7 did not affect either total or phospho-FOXO3A expression . 
Conclusion

Conclusion:
These results suggest that NKX3.1 negatively regulates the TMPRSS2 promoter activity through binding to the conserved sites. The loss of its expression due to either decreased stability or monoallelic loss may result into elevated expression of ERG in the TMPRSS2-ERG fusion context of prostate cancer. These data suggest that two common gene defects in prostate cancer may work together to promote cancer and this information may lead to new ideas for treatment. This is a very important finding and is being actively pursued at CPDR.
Mr. Emmanuel Woode (2008) Biological function of truncated ERG (ERG 8) protein
• ERG is a common oncogenic alteration in prostate cancer. 
Ms.Fiteh Yelekal (2008)
Increased levels of SPARC (osteonectin) in human prostate cancer tissues and its association with clinical metastasis.
• Previous research at CPDR identified SPARC protein as a central node in the gene networks differentially expressed in poorly differentiated aggressive prostate cancers in comparison to moderate well differentiated tumors.
• High SPARC expression in CaP mRNA levels was associated with an increased risk of PSA recurrence.
• Comparative quantitative determination of SPARC protein by immuno-histochemistry showed significant association of high SPARC protein levels in primary tumor of patients with metastasis in comparison to primary tumors of patients without metastasis.
Conclusion: This study provided very promising results with respect to an early prognostic biomarker for prostate cancer progression which is being pursued actively by CPDR investigators.
Ms. Zainab Afzal (2009) ERG is a transcription factor which belongs to the ETS family
• ERG is one of the most common oncogeneic activation known in prostate cancer. Different versions of ERG mRNA and proteins: Type I, near full length isoforms (ERG 1, 2 and 3) and Type I1, ETS domain lacking isoforms (ERG 8, EPC) are expressed in prostate cancer cells. Using HEK293 cell culture model and ectopic expression of various ERG forms, their subcellular localization and transcription factor function were studied. The Type I ERG isoforms, ERG1, ERG2, WT-ERG3, and TMPRSS2-ERG3 were localized to the nucleus.
• The type II ERG,TMPRSS2-ERG8 was localized to the cytoplasm.
• Type I ERG isoforms showed strong ERG transcription activity where as type II ERG isoform was virtually inactive.
Conclusion:
These results suggested that ETS DNA-binding domain is required for the nuclear localization of a ERG protein. Transcriptional efficacy of ERG isoforms using reporter assays revealed that the nuclear localization of ERG isoforms is required for their function as trancription regulators. It remains to be established if there is any interaction between Type I and Type II ERG proteins which is currently being studied at CPDR.
Ms. Emelia Daka (2009)
Defining mir-127 in benign epithelial cells of tumor bearing prostate glands
• ERG is one of the most common oncogeneic activation known in prostate cancer. Potential regulation of ERG expression by micro-RNAs was studied. Micro-RNA sites were identified in ERG sequence by bio-informatics analyses. ERG 3' UTR sequence contained mir-127 and mir-21 binding sites.
• mir-127 was present in benign prostate tissue away from prostates tumors.
• mir-127 was undetected in ERG expressing prostate cells
Conclusion:
Presence of mir-127 expression in benign prostate cells and lack of its expression in tumor cells suggested a potential negative regulatory function of mir-1271 in controlling ERG expression. These novel findings deserve further study.
Ms. Heran Kalyie (2009) Human Herpes Virus 8 in prostate cancer initiation and progression
• Role of pathogens in prostate cancer onset remains a hot topic, however, there is no firm data to support biological role of viruses or bacteria in prostate cancer. This study focused on the assessment of HHV8, which is associated with Kaposi Sarcoma, in prostate cancer cell lines. CaP cell lines can be infected with a KSHV based on virion entry using KSHV219.
• In cell invasion, KSHV infected CaP cells (DU-145) had the tendency to invade faster compared to uninfected DU-145 • KSHV infection may stimulate the growth of prostate tissue, leading to a more aggressive disease
Conclusion:
The results suggested that KSHV may be present in prostate cancer cell lines including LNCaP, DU145 and PC3. Presence of KSHV in prostatic reservoir may lead to initiation and/or progression of prostate cancer. More work is warranted to confirm these intriguing results.
Functional analysis of ERG: Role in trans-differentiation
• Since ERG is the most common cancer gene defect in prostate cancer and prostate cancer is known to metastasize to bone, potential role of ERG in bone metastasis was studied. VCaP cells (derived from a human vertebral metastatic lesion of CaP) expressing high levels of ERG trans-differentiates into osteogenic cells in the presence of osteogenic media conditions. • Down regulation of ERG expression was achieved using ERG siRNA.
• 
Conclusion:
WT-ANXA7 inhibits FGF8 expression which may contribute to inhibition of prostate epithelial cell proliferation. Loss of ANX7 in prostate tumors may contribute to prostate cancer cell proliferation.
Ms. Tseday Tegegn (2009)
Functional analysis of ERG in prostate cancer cells
• ERG is a potentially causal common oncogenic alteration in prostate cancer. Cancer biologic properties of ERG were analyzed by ERG silencing in a prostate cancer cell line (VCaP) and by overexpression of ERG in an immortalized normal prostate cell line (BPH1). ERG knockdown inhibited the cell growth and altered the morphology of VCaP cells. ERG knockdown in VCaP cells correlated with increased PSA and other prostate differentiation markers.
• ERG overexpression in BPH1 cells showed an increased cell migration as compared to the control BPH1 cells.
• Reciprocal relationship of ERG and PSA was further analyzed in prostate cancer patients. Data analysis shows that patients with ≤4ng/mL serum PSA had higher frequency of ERG positive CaP ( ERG positive, 79% vs. ERG negative, 67%) than patients with > 4 ng/mL serum PSA (ERG positive, 56% vs. ERG negative, 52%)
Conclusion: ERG knockdown experiments in VCaP cells and overexpression studies in BPH1 cell lines highlighted pro-cancer functions of ERG.
Ms. Preety Upadhyay (2009) Assessing ERG as a regulator of ARR2-Probasin promoter
• Previous studies from CPDR suggested that ERG may inhibit androgen receptor (AR) functions. ARR2-probasin promoter is AR regulated and has been commonly used in the generation of prostate targeted transgenic mouse. Due to difficulties in generating ARR2-probasin promoter driven ERG transgenic mice in several laboratories, there has been concern over less optimal function of ARR2-probasin promoter, likely due to inhibition of AR by ERG. Using transcriptional trans-activation assay, effect of ERG was evaluated on ARR2-probasin promoter.
• Transcriptional activation assays indicate that ERG acts as a repressor of ARR2PB-driven luciferase gene in LNCaP cells.
• No significant change in ARR2PB-Luc activity in VCaP with ERG
Conclusion: ERG suppresses the ARR2PB promoter. The lack of suppression of transcriptional activity in VCaP cells may be explained as VCaP cells express high levels of endogenous ERG. These data suggested for evaluation of potential effects of ERG on ARR2-PB promoter in mouse prostate cells.
Ms. Nicola Eva Abdul (2010)
TMPRSS2-ETS related gene fusions in mouse models for prostate cancer
• TMPRSS2-ERG gene fusions are common in human prostate cancer. Using Erg protein expression as a surrogate for theTmprss2-Erg alterations, prostate tumors from the TRAMP transgenic mouse were assessed for gene fusions.
• Wild type mice showed Erg expression only in endothelial cells of prostate. ERG transgenic mice showed abundant ERG protein expression in the nucleus of prostate luminal epithelial cells, in addition to endogenous Erg expression in endothelial cells.
• TRAMP mouse prostates showed expression mostly in the endothelial cells • Focal ERG expression was seen in the luminal epithelial cells of only 1 out of 50 TRAMP mouse prostates.
Conclusion:
The factors that induce specific chromosomal rearangements of TMPRSS2-ERG are not well defined. Although, biological factors such as viruses are suspected to be causative factors, specific chromosomal rearrangements in prostate cancer have not been characterized. Our experiments using TRAMP mouse prostates did not show a convincing evidence of ERG alterations in TRAMP mice.
Ms. Zainab Afzal (2010) CPDR Multi-disciplinary Prostate Cancer Clinic: Educational experience shadowing patients diagnosed with prostate cancer
• CPDR Multi-disciplinary clinic is a state-of-the-art treatment facility at the Walter Reed Army Medical Center for patients undergoing treatment for prostate cancer. It is also a great learning environment for residents and medical students. This nursing student during her second term at CPDR requested for the internship opportunity at the clinic. Under the guidance of a nurse educator, she interacted with prostate cancer patients through various stages of diagnosis, treatment options and recovery.
• She developed a great perspective on how differently each patient reacted and coped to the diagnosis of prostate cancer.
• She also developed a better understanding of various treatments being offered to patients.
• She related her experience to fellow students doing cancer biology research in the laboratory.
Conclusion:
Shadowing a number of patients during various stages of prostate cancer diagnosis, treatment and recovery, as well as being mentored by many clinical staff members, afforded a rich educational opportunity to understand this disease from the clinician's and the patient's perspective.
Student: Ms. Christelle Donfack (2010)
Characterization of ERG protein in prostate cancer and other tumor cell lines
• Although ERG gene was discovered almost 24 years ago, good quality ERG specific antibodies were not available for confident evaluation of ERG protein in experimental models and human cancers. Recent development of highly specific ERG monoclonal antibody at CPDR has led to first opportunities in the evaluation of ERG protein in diverse cancer research contexts. To understand ERG protein functions in different cancer types and normal context, ERG protein expression was analyzed in HUVEC (normal endothelial cells), COLO 320 (colon carcinoma), NCI-H660 (prostate carcinoma), VCaP (prostate carcinoma), KG1 (acute myelogenous leukemia) and MOLT4 (acute lymphoblastic leukemia) cell lines.
• ERG siRNA effectively downregulated ERG expression in HUVEC, COLO 320, NCI-H660 and VCaP cells. This also established the specificity of ERG MAb for ERG protein detection in different tumor cell lines.
• ERG protein was predominantly detected in the nucleus of endothelial cells and prostate cancer and leukemia cell lines. ERG protein was detected in nucleus as well as cytoplasm of colon cancer cell line.
Conclusion:
ERG is a nuclear transcription factor and regulates the expression of downstream target genes. Although, ERG protein is seen in various tumors and HUVEC cells, the molecular weights and levels of expression were varied. ERG protein was localized in the nucleus of KG1, MOLT4, COLO320 and VCaP. In addition to nucleus, COLO320 cells also showed ERG expression in cytoplasm. These data laid the foundation for evaluation of ERG function cell lines from different cancers which could lead to optimal therapeutic strategies.
Ms. Juliet Chijioke (2010)
Androgen receptor (AR) regulates NEDD4-1, an oncogenic protein, in prostate cancer cells.
• AR plays important role in normal prostate development and differentiation. Previous research at CPDR established a new mechanism of regulation of the AR by an androgen regulated protein, PMEPA1, which binds to NEDD4. In continuation of these studies effects of AR on NEDD4-1 was evaluated. AR was up-regulated by synthetic androgen R1881 in both LNCaP and VCaP cells. 
Student Tracking and Extended Mentoring
The students trained under this program are in contact with the PD, Co-PIs, Mentors and to continue to interact and discuss their progress and guidance in choosing the appropriate career. Most of the students have chosen to continue education in obtaining graduate degree in biology or Medical sciences and related areas. The following is the list of the students and their status as of 2011:
Mr. Chiedozie Joseph Ayika: Graduated and working at the USUHS, applying to Nursing School Mr. 
CONCLUSIONS:
Prostate cancer (CaP) is a major health concern for men in the USA with expected 217,730 new cases and 32,050 deaths in 2010. African American (AA) men have a 60% higher incidence rate and twice the death rate of white men, and it is the second leading cause of cancer-related death in AA men. Lack of minority research investigators has often been cited as one of the barriers to research addressing minority health issues, e.g., high CaP incidence in AA patients. Through the DoD-PCRP grant, USU-CPDR in partnership with UDC launched an educational effort to train minority students in prostate cancer research. The goal of the program is to increase the number of minority students pursuing careers in prostate cancer research.
During three years (2008) (2009) (2010) of the grant, this collaboration has trained 16 meritorious UDC students who were selected after a rigorous selection by USU-CPDR and UDC selection committee. The students were assigned to the faculty members of USU who are focusing on specific research projects in CaP basic science and translational research in a multi-disciplinary setting involving cancer biologists, urologists, pathologists and biomedical informatics experts. These state-of-the-art projects represent high-impact research addressing CaP tumor biology, biomarkers, patient treatment and education. In addition to their project focus, students participated in weekly seminars presented by the USU-CPDR faculty and staff and guest speakers. This provided students the exposure to key issues in CaP research. Students prepared and presented their research goals and objectives and progress in biweekly presentations. At the end of the training, each student made presentations of the completed project in the form of a written report and a public seminar. The students also presented their research projects at the institutional and national meetings focusing the HBCU training and research. The program engaged prostate cancer researchers and students in mutually beneficial interactions resulting in a very rewarding experience for mentors as well as students in creating and maintaining a strong academic "pipeline" of students, who are likely to pursue professional career in medicine or bio-medical research. The excitement and success of this program is represented by training of 4 additional students than originally intended.
The HBCU summer training program between UDC and USU-CPDR has provided ground breaking unique opportunities for UDC students, who have expressed gratitude for this eye opening exposure and future commitment to professional training in prostate cancer research or similar biomedical research career.
During the training period, the students learned the following:
• Basic skills in planning and execution of a research project focused on a defined question related to molecular and cell biology of CaP or translational CaP research • Presentation and development of a practical idea and its significance to CaP • Importance of CaP research in high-risk populations, such as African Americans • Preparation of high-quality slide presentations on assigned topics • Maintenance of an electronic record of experiments and preparation of a final written report.
• Appreciation of the power of scientific research and its application in decreasing suffering from a disease such as cancer • Appreciation of the dedication, perseverance, and effort it takes to perform research of the highest quality in a laboratory 26
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None Located on the grounds of Bethesda's National Naval Medical Center and across from the National Institutes of Health, USU is the nation's federal school of medicine and graduate school of nursing. The university educates health care professionals dedicated to career service in the Department of Defense and the U.S. Public Health Service. Students are active-duty uniformed officers in the Army, Navy, Air Force and Public Health Service, who are being educated to deal with wartime casualties, national disasters, emerging infectious diseases, and other public health emergencies. Of the university's more than 4,000 physician alumni, the vast majority serve on active duty and are supporting operations in Iraq, Afghanistan, and elsewhere, offering their leadership and expertise.
For more information, contact the Office of External Affairs at 301-295-1219.
-end - The students presented the summary of their training and research accomplishments at USU to leaders from the participating organizations.
The presenters and the title of their concluding presentations were as follows: Located on the grounds of Bethesda's National Naval Medical Center and across from the National Institutes of Health, USU is the nation's federal school of medicine and graduate school of nursing. The university educates health care professionals dedicated to career service in the Department of Defense and the U.S. Public Health Service. Students are active-duty uniformed officers in the Army, Navy, Air Force and Public Health Service who are being educated to deal with wartime casualties, natural disasters, emerging infectious diseases, and other public health emergencies. Of the university's nearly 4,400 physician alumni and more than 400 advanced practice nurses, the vast majority serve on active duty and are supporting operations in Iraq,
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Afghanistan, and elsewhere, offering their leadership and expertise. The University also has graduated more than 600 public health professionals.
For more information about USU and its programs, visit www.usuhs.mil. The Uniformed Services University of the Health Sciences (www.usuhs.mil) is the nation's federal health sciences university. USU students are primarily active duty uniformed officers in the Army, Navy, Air Force and Public Health Service who are being educated to deal with wartime casualties, emerging infectious diseases and other public health emergencies. Of the university's more than 4,500 physician alumni, the vast majority are supporting operations in Iraq, Afghanistan and elsewhere, offering their leadership and expertise.
For more information about USU and its programs, visit www.usuhs.mil. 
Multi-Institution Distance Learning Option for Fall
Do you need a university-wide social science requirement? Do you want to be part of a nation-wide learning community? Do you want to interact and talk to leading politicos in a synchronous interview format with C-SPAN and other institutions? Then you need to enroll in the distance learning course Bureaucracy and Policy Making (1169-346) being held on Thursdays from 2 p.m. -5 p.m. The course studies the role of bureaucracies in policymaking and their interactions with the other elements of the political system. Discuss such topics as the sources of bureaucratic power, the bureaucratic policy process, and the interactions of bureaucracy with the executive, legislative, non-governmental structure, and the public.
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